HRMY(Harmony Biosciences Holdings, Inc.) · 财务报表

HRMY(Harmony Biosciences Holdings, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$305.44M$437.86M$582.02M$714.73M$868.45M
毛利润$249.92M$354.37M$460.79M$557.92M$670.11M
营业利润$87.53M$120.19M$192.03M$190.83M$208.47M
净利润$34.60M$181.47M$128.85M$145.49M$158.69M
经营现金流$98.56M$144.47M$219.39M$219.82M$348.20M
自由现金流$98.26M$144.29M$219.07M$218.67M$347.89M
摊薄每股收益$0.58$2.97$2.13$2.51$2.71

Harmony Biosciences Holdings, Inc. HRMY